MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, TTNP made $657K in revenue. -$689K in net income. Net profit margin of -104.87%.

Income Overview

Revenue
$657K
Net Income
-$689K
Net Profit Margin
-104.87%
EPS
-$0.65
Unit: Thousand (K) dollars
Revenue Breakdown
    • General and administrative

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-06-30
2024-09-30
2024-06-30
General and administrative
657 754 2,074
Total operating expenses
657 754 2,074
Loss from operations
-657 -754 -2,074
Other expense
-32 -9 -
Other nonoperating expense
--19
Interest income
0 --
Other expense, net
-32 -9 -19
Net loss
-689 -763 -2,093
Basic net loss per common share
-0.65 -0.83 -2.29
Diluted net loss per common share
-0.65 -0.83 -2.29
Weighted average shares used in computing basic net loss per common share
1,065,000 914,000 914,000
Weighted average shares used in computing diluted net loss per common share
1,065,000 914,000 914,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$689K Other expense, net-$32K Loss from operations-$657K Other expense-$32K Total operatingexpenses$657K General andadministrative$657K

TITAN PHARMACEUTICALS INC (TTNP)

TITAN PHARMACEUTICALS INC (TTNP)